Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nano Discovery is a private Orlando, Florida biotechnology company focused on rapid immune health testing, primarily for livestock and companion animals. Its lead commercial product, the D2Dx immunity test, is a one-minute blood test designed to assess animal immune status at the point of care without requiring centralized laboratory turnaround. The company develops, manufactures, and sells test kits and related instrumentation, and it also supports research applications in human and non-human primate immune studies. The underlying D2Dx platform is based on nanoparticle-enabled immunoassay technology and has also been explored for pathogen and antibody detection applications, including prior work related to Zika testing. Overall, Nano Discovery appears to be a diagnostics and animal-health platform company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nano Discovery.